Zobrazeno 1 - 10
of 45
pro vyhledávání: '"I. G. Rekhtina"'
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 83-88 (2022)
Neutrophilic leukocytosis is not specific for multiple myeloma (MM) and is a reason for the exclusion of myeloproliferative neoplasm.A clinical case of MM patient with neutrophilic hyperleukocytosis (75 х 109/L), liver and spleen enlargement at the
Externí odkaz:
https://doaj.org/article/cf5f3282a05e4d4b80e01f53f5234f8c
Publikováno v:
Онкогематология, Vol 16, Iss 3, Pp 74-82 (2021)
Objective of the study: analysis of AL-amyloidosis (AL-A) diagnostics in real clinical practice and to determine the main approaches for the earlier detection of this disease.Materials and methods. A retrospective analysis of medical records of 34 pa
Externí odkaz:
https://doaj.org/article/96f5f7a1f70d4719a864d17f6036b3d6
Autor:
I. G. Rekhtina, E. V. Kazarina, E. S. Stolyarevich, A. M. Kovrigina, V. N. Dvirnyk, S. M. Kulikov, L. P. Mendeleeva
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 63-69 (2020)
Aim.Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast nephropathy (MCN) based on the study of kidney biopsy. Materials and methods.Renal pathologi
Externí odkaz:
https://doaj.org/article/334f035c8652478d9f44c3b8758a6230
Autor:
L. P. Mendeleeva, I. G. Rekhtina, A. M. Kovrigina, I. E. Kostina, V. A. Khyshova, N. K. Arytyunyan, W. E. Mamonov, V. G. Savthenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 85-89 (2020)
Our case demonstrates severe bone disease in primary AL-amyloidosis without concomitant multiple myeloma. A 30-year-old man had spontaneous vertebral fracture Th8. A computed tomography scan suggested multiple foci of lesions in all the bones. In bon
Externí odkaz:
https://doaj.org/article/ca469b7fe02e42c69d464ad1eb4cb5da
Autor:
M. V. Firsova, L. P. Mendeleeva, M. V. Solovev, I. G. Rekhtina, O. S. Pokrovskaya, E. S. Urnova, N. P. Soboleva, V. N. Dvirnyk, G. A. Klyasova, L. A. Kuzmina, V. G. Savchenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 70-76 (2020)
Aim.To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent renal failure. Materials and methods.During a period from May 2010 to December 2016
Externí odkaz:
https://doaj.org/article/a01f94a3ddbe462b9ab261e3486d0445
Autor:
I. G. Rekhtina, L. P. Mendeleeva
Publikováno v:
Онкогематология, Vol 14, Iss 1, Pp 8-13 (2019)
Currently, there has been a marked increase in the number of opportunities for relapsed and refractory multiple myeloma treatment due to emergence of new target drugs. These include pomalidomide, a 3 rd generation immunomodulator capable of treating
Externí odkaz:
https://doaj.org/article/20e4196b2dba424b8ec8cf0a40ff5353
Publikováno v:
Terapevticheskii arkhiv. 94(1)
Paraprotein is a laboratory biomarker of plasma cell tumors and other lymphoproliferative diseases. Its determination is necessary for diagnosing, monitoring and assessment of therapy effectiveness. The lecture presents the main methods of qualitativ
Autor:
E.V. Kazarina, L P Mendeleeva, Alla M. Kovrigina, V N Dvirnyk, Sergei M. Kulikov, Ekaterina S Stolyarevich, I G Rekhtina
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 63-69 (2020)
Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast nephropathy (MCN) based on the study of kidney biopsy.Renal pathological findings were studied in 3
Autor:
Olga S. Pokrovskaya, M V Solovev, N P Soboleva, Larisa A. Kuzmina, E S Urnova, I G Rekhtina, Larisa P. Mendeleeva, Maya Firsova, V N Dvirnyk, Valeriy G. Savchenko, G A Klyasova
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 70-76 (2020)
To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent renal failure.During a period from May 2010 to December 2016 fourteen MM patients with dial
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 70-74 (2019)
Aim: to determine serum free light chains (FLC) level by patients with multiple myeloma (MM) and dialysis - dependent renal impairment in which the amount Bence Jones (BJ) protein in the urine met the criteria of hematological response. Patients and